Picture of ORYZON Genomics SA logo

ORY — ORYZON Genomics SA News Story

0.000.00%
es flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapSucker Stock

Brief: Oryzon - Receives Non-Refundable Grant Of 13.26 Mln Euro For Its Vandam Project Within Med4cure

May 8 (Reuters) - Oryzon Genomics SA ORY.MC:

RECEIVES NON-REFUNDABLE GRANT OF €13.26 MILLION FOR ITS VANDAM PROJECT WITHIN MED4CURE

FUNDING COVERS 64% OF ORYZON’S VANDAM PROJECT TOTAL BUDGET

Source text: ID:nCNMW9GcPF

Further company coverage: ORY.MC

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))

Recent news on ORYZON Genomics SA

See all news